pantoprazole has been researched along with Hypokalemia in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fatuzzo, P | 1 |
Portale, G | 1 |
Scollo, V | 1 |
Zanoli, L | 1 |
Granata, A | 1 |
Mojadidi, MK | 1 |
Hovnanians, N | 1 |
Kaufmann, MR | 1 |
Hill, JA | 1 |
2 other studies available for pantoprazole and Hypokalemia
Article | Year |
---|---|
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements; | 2017 |
An Unusual Presentation of QT Prolongation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Action Potentials; Anti-Infective Agents; Arrhythmias, Card | 2016 |